Simcere Pharmaceutical Group Limited
2096.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.97B
Close$
Share Statistics
| Market cap | $27.97 Billion |
|---|---|
| Enterprise Value | $27.31 Billion |
| Dividend Yield | $0.21 (1.90%) |
| Earnings per Share | $0.54 |
| Beta | 0.66 |
| Outstanding Shares | 2,551,796,123 |
Return
| Return on Equity | 25.87% |
|---|---|
| Return on Assets | 15.77% |
| Return on Invested Capital | 25.26% |
Valuation & Multiples
| P/E Ratio | 15.2 |
|---|---|
| PEG | 42.93 |
| Price to Sales | 1.82 |
| Price to Book Ratio | 3.63 |
| Enterprise Value to Revenue | 1.73 |
| Enterprise Value to EBIT | 9.37 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$5.22 B
Average shareholder expectationNext Earnings Call
Expected Date
March 25, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$5.28 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Simcere Pharmaceutical Group Limited
7,064 employees
CEO: Yunshu Zhou Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, inc...